Physician profile
Scott C Marshall
NPI 1770890964
$1,936.28
in general payments reported to CMS, 2019-2025
10 companies · $26.51 in 2025
The $26.51 reported for 2025 was less than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,500 · 2020: $67.47 · 2021: $133 · 2022: $133 · 2023: $33.38 · 2024: $42.55 · 2025: $26.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $102.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirona Dental, INC. | $750.00 | 2019 | |
| Patterson Companies, INC. | $750.00 | 2019 | |
| Nobel Biocare USA | $249.21 | 2020-2023 | Nobelactive |
| Align Technology, INC. | $60.16 | 2020-2024 | Invisalign, Itero Element 5d Plus |
| Implant Direct Sybron International LLC | $33.29 | 2021 | |
| Envista Holdings Corporation | $26.51 | 2025 | Maxcem Elite |
| Zimvie INC. | $22.21 | 2024 | |
| Biohorizons Implant Systems INC. | $16.52 | 2020 | |
| Dentsply Sirona INC | $16.04 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Marshall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.